A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Clinical trial NCT03622580 · COMPLETED
Trial details
- NCT number
- NCT03622580
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2020-10-20
- Enrollment
- 940
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.